| Ma, Xinlong |
NCT03002207: Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation |
|
|
| Completed | N/A | 25 | RoW | Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge, The defect is sutured | Zhanghao | Lumbar Disc Herniation | 12/24 | 12/24 | | |
| Completed | N/A | 39797 | RoW | | McMaster University, Canadian Institutes of Health Research (CIHR), McMaster Surgical Associates, National Health and Medical Research Council, Australia, Hamilton Health Sciences Corporation | Fractures or Dislocations | 11/23 | 11/23 | | |
| Zhang, Kaihui |
NCT03002207: Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation |
|
|
| Completed | N/A | 25 | RoW | Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge, The defect is sutured | Zhanghao | Lumbar Disc Herniation | 12/24 | 12/24 | | |
| Xu, Baoshan |
NCT03002207: Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation |
|
|
| Completed | N/A | 25 | RoW | Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge, The defect is sutured | Zhanghao | Lumbar Disc Herniation | 12/24 | 12/24 | | |
| Zheng, Hong |
NCT02584478 / 2021-003871-32: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) |
|
|
| Active, not recruiting | 3 | 294 | Europe, US, RoW | AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol | Advenchen Laboratories, LLC, Advenchen Laboratories, LLC | Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma | 10/24 | 12/24 | | |
BRAND, NCT06141265: Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab |
|
|
| Recruiting | 2 | 116 | RoW | Niraparib | Peking University Cancer Hospital & Institute | Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma | 09/26 | 09/27 | | |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | 06/26 | 12/26 | | |
NCT06420973: RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression |
|
|
| Recruiting | 2 | 54 | RoW | RC48+carboplatin±bevacizumab | Peking University Cancer Hospital & Institute | Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | 05/27 | 09/27 | | |
NCT06434610: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. |
|
|
| Recruiting | 2 | 90 | RoW | B013, Paclitaxel, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Platinum-resistant Recurrent Ovarian Cancer | 12/26 | 12/26 | | |
NCT06308406: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer |
|
|
| Recruiting | 1/2 | 54 | RoW | Bevacizumab； HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Recurrent Ovarian Cancer | 10/25 | 10/25 | | |
NCT04029909: A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer |
|
|
| Recruiting | 1 | 12 | RoW | Gimatecan 0.6mg/m2/d, 0.8mg/m2/d, 0.4mg/m2/d | Lee's Pharmaceutical Limited | Ovarian Epithelial Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | 12/19 | 12/22 | | |
NCT06614751: A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway |
|
|
| Not yet recruiting | 1 | 112 | RoW | DAT-2645 tablet | Danatlas Pharmaceuticals Co., Ltd | Solid Cancers, BRCA Mutation, HRD Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Pancreatic Cancer, Endometrial Cancer, Gastric Cancer, Advanced Cancer, Metastatic Solid Tumors | 11/26 | 06/27 | | |
ERAS, NCT06182488: Enhanced Recovery After Surgery () in Patients Undergoing Emergency Laparotomy |
|
|
| Recruiting | N/A | 160 | RoW | ERAS protocols, Conventional protocols | Tianjin Medical University, Tianjin Hospital | Acute Abdomen, Abdominal Trauma, Emergency Surgery | 11/23 | 05/24 | | |
| Chao, Aijun |
EFFECT, NCT05902078: Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis |
|
|
| Recruiting | 4 | 300 | RoW | Eldecalcitol capsules, Edirol, Calcitriol capsules, Haidewei | Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Chugai Pharma China Co., Ltd. | Low Bone Mineral Density, Postmenopausal Osteoporosis | 06/25 | 12/25 | | |
| Buunaaim, Alexis |
NCT04207892: Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children |
|
|
| Recruiting | N/A | 1000 | Europe, Canada, US, RoW | Conservative (non-surgical) treatment, Surgical treatment | AO Innovation Translation Center | Long Bone Fractures | 05/27 | 12/28 | | |
| Konstantopoulou, Anna |
NCT04207892: Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children |
|
|
| Recruiting | N/A | 1000 | Europe, Canada, US, RoW | Conservative (non-surgical) treatment, Surgical treatment | AO Innovation Translation Center | Long Bone Fractures | 05/27 | 12/28 | | |
| Yang, Qiang |
| Recruiting | N/A | 640 | RoW | | Peking University Third Hospital, Hebei Medical University Third Hospital, Tianjin Hospital, West China Hospital, Qilu Hospital of Shandong University, The First Affiliated Hospital of Nanchang University, Henan Provincial People's Hospital, The First People's Hospital of Yunnan | Degenerative Scoliosis, Scoliosis Lumbar Region | 08/24 | 08/24 | | |
| Dai, Bin |
ERAS, NCT06182488: Enhanced Recovery After Surgery () in Patients Undergoing Emergency Laparotomy |
|
|
| Recruiting | N/A | 160 | RoW | ERAS protocols, Conventional protocols | Tianjin Medical University, Tianjin Hospital | Acute Abdomen, Abdominal Trauma, Emergency Surgery | 11/23 | 05/24 | | |
